Garde Capital’s Arcosa ACA Stock Holding History

Garde Capital’s Portfolio ACA Stock Details ACA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5	Closed	-$434	–	238
2025 Q2	$434	Hold	5	–	–	﹤0.01%	743
2025 Q1	$386	Buy	+5	New	+$459	﹤0.01%	735

Other funds holding ACA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Garde Capital's ACA Position: Q3 2025 in Review

Garde Capital sold out of Arcosa (ACA) in Q3 2025, closing a stake of 5 shares — an estimated $434 sold.

Garde Capital first reported a position in ACA in Q1 2025 and held it in 2 quarters. The position peaked at $434 in Q2 2025. 364 funds tracked by Wall St. Rank hold ACA as of Q3 2025.

Garde Capital reported no remaining Arcosa position as of Q3 2025 after selling out during the quarter.
Garde Capital sold 5 Arcosa shares in Q3 2025, an estimated $434.
Garde Capital first reported a position in Arcosa in Q1 2025 and held it in 2 quarters.
Garde Capital's Arcosa position peaked at $434 in Q2 2025.
364 funds tracked by Wall St. Rank held Arcosa as of Q3 2025.

Based on Garde Capital's 13F filing for Q3 2025, filed 16 Dec 2025.